Medicines Co. Beats Mylan In Generic-Angiomax Fight
An Illinois federal court ruled Monday that Mylan Inc.'s proposed generic version of the anticoagulant Angiomax infringed one of The Medicines Co.'s patents for the drug and held that Mylan had...To view the full article, register now.
Already a subscriber? Click here to view full article